Literature DB >> 4068145

Interaction between HeLa cells and adenovirus type 2 virions neutralized by different antisera.

C E Wohlfart, U K Svensson, E Everitt.   

Abstract

Three adenovirus type 2-specified immunogens elicited neutralizing antibodies when injected into rabbits; these were the fiber, the hexon, and the penton base. Adenovirus type 2 virions, neutralized by antihexon- or anti-penton base antisera, attached to HeLa cells to the same extent as untreated control virus, and after attachment, neutralized viruses also became sensitive to DNase treatment. A fraction of 75 to 80% of the attached antibody-treated virions penetrated the plasma membrane, which should be compared with an 84 to 88% penetration level in the control series. A majority of the antihexon-neutralized virions was found in intracellular vesicles, as revealed with an electron microscope, but in the case of anti-penton base neutralization, a maximum of 50% of the virions was retained within vesicles, and ca. 30% was free in the cytoplasmic compartment. A value greater than 45% was never obtained for neutralization with a monospecific anti-penton base antiserum, which could imply the existence of alternative pathways for virus penetration into HeLa cells--one of these being sensitive to treatment with anti-penton base antiserum. Antisera containing antifiber specificities efficiently aggregated virions, and the aggregation data mirrored the degree of neutralization. Antifiber-neutralized virions attached to cells to a three- to five times greater extent than untreated control virus, but the former virions had a reduced ability to become sensitive to DNase treatment. Around 15% of the attached antifiber-treated virions was found as large aggregates inside multivesicular bodies or lysosomes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4068145      PMCID: PMC252662          DOI: 10.1128/JVI.56.3.896-903.1985

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  THE INTRACELLULAR UNCOATING OF POXVIRUS DNA. I. THE FATE OF RADIOACTIVELY-LABELED RABBITPOX VIRUS.

Authors:  W K JOKLIK
Journal:  J Mol Biol       Date:  1964-02       Impact factor: 5.469

2.  Sensitization and neutralization of adenovirus by specific sera against capsid subunits.

Authors:  G Wadell
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

3.  Cytotoxicity by antigen aggregation. Adenovirus neutralization assays as a model.

Authors:  L Kjellén
Journal:  Arch Gesamte Virusforsch       Date:  1972

4.  Adenovirus neutralization--behavior of virion derived capsid components in the production of in vitro neutralizing antibody.

Authors:  K F Shortridge
Journal:  Microbios       Date:  1972

5.  The relationship between the soluble antigens and the virion of adenovirus type 3. IV. Immunological complexity of soluble components.

Authors:  E Norrby
Journal:  Virology       Date:  1969-04       Impact factor: 3.616

6.  Structural proteins of adenoviruses. VI. On the antigenic determinants of the hexon.

Authors:  U Pettersson
Journal:  Virology       Date:  1971-01       Impact factor: 3.616

7.  Structural proteins of adenoviruses. IV. Sequential degradation of the adenovirus type 2 virion.

Authors:  L Prage; U Pettersson; S Höglund; K Lonberg-Holm; L Philipson
Journal:  Virology       Date:  1970-10       Impact factor: 3.616

8.  Mechanism of the arginine requirement for adenovirus synthesis. I. Synthesis of structural proteins.

Authors:  E Everitt; B Sundquist; L Philipson
Journal:  J Virol       Date:  1971-11       Impact factor: 5.103

9.  The purification of adenovirus neutralizing antibody: adenovirus type 5 hexon immunoadsorbent.

Authors:  A T Haase; H G Pereira
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

10.  Cytotoxicity of adenovirus-antibody aggregates: sensitivity to different cell strains, and inhibition by hexon antiserum and by complement.

Authors:  L Kjellén; J Ankerst
Journal:  J Virol       Date:  1973-07       Impact factor: 5.103

View more
  23 in total

1.  The subgenus-specific C-terminal region of protein IX is located on the surface of the adenovirus capsid.

Authors:  A Akalu; H Liebermann; U Bauer; H Granzow; W Seidel
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Regulation of virus neutralization and the persistent fraction by TRIM21.

Authors:  W A McEwan; F Hauler; C R Williams; S R Bidgood; D L Mallery; R A Crowther; L C James
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

3.  Antibodies with specificities against a dispase-produced 15-kilodalton hexon fragment neutralize adenovirus type 2 infectivity.

Authors:  M J Varga; T Bergman; E Everitt
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  Structure-based identification of a major neutralizing site in an adenovirus hexon.

Authors:  Susan L Pichla-Gollon; Mark Drinker; Xiangyang Zhou; Feng Xue; John J Rux; Guang-Ping Gao; James M Wilson; Hildegund C J Ertl; Roger M Burnett; Jeffrey M Bergelson
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

5.  Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture.

Authors:  F M Ruggeri; H B Greenberg
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

6.  Characterization of group II avian adenoviruses with a panel of monoclonal antibodies.

Authors:  J V van den Hurk; S van Drunen Littel-van den Hurk
Journal:  Can J Vet Res       Date:  1988-10       Impact factor: 1.310

7.  Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms.

Authors:  C Wohlfart
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

8.  Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes.

Authors:  J Gall; A Kass-Eisler; L Leinwand; E Falck-Pedersen
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Adenovirus uncoating and nuclear establishment are not affected by weak base amines.

Authors:  E Rodríguez; E Everitt
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Infectious entry pathway of adenovirus type 2.

Authors:  M J Varga; C Weibull; E Everitt
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.